AME case reports · 2026
Seroma formation following percutaneous needle aponeurotomy and corticosteroid injection for Dupuytren's contracture: first case report in the literature.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Seth Ishith, Mon Yi, Sacks Brett K, Rozen Warren M
Аннотация
BACKGROUND: Dupuytren's contracture is a progressive fibroproliferative condition of the palmar fascia resulting in finger flexion deformities. Commonly reported complications following percutaneous needle aponeurotomy (PNA) may include skin tears, infections, nerve injuries, tendon lacerations and regional pain syndromes. Seroma formation is not known to develop following PNA, particularly when combined with corticosteroid injections (CSIs).
CASE DESCRIPTION: We describe the first documented case of an infected seroma following combined PNA and CSI in a 67-year-old female. A 67-year-old female developed a painless cystic lesion in her palm that she self-managed with compression following PNA and CSI. However, 6 weeks post-procedure, the cystic lesion progressed to infection, which resolved with oral antibiotics and drainage. No cases of seroma have been reported in studies evaluating corticosteroid-assisted PNA.
CONCLUSIONS: This case highlights the importance of recognising infected seromas as a potential, albeit rare, post-procedural complication following corticosteroid-assisted PNA. Further investigation into risk factors and preventive measures is warranted.
CASE DESCRIPTION: We describe the first documented case of an infected seroma following combined PNA and CSI in a 67-year-old female. A 67-year-old female developed a painless cystic lesion in her palm that she self-managed with compression following PNA and CSI. However, 6 weeks post-procedure, the cystic lesion progressed to infection, which resolved with oral antibiotics and drainage. No cases of seroma have been reported in studies evaluating corticosteroid-assisted PNA.
CONCLUSIONS: This case highlights the importance of recognising infected seromas as a potential, albeit rare, post-procedural complication following corticosteroid-assisted PNA. Further investigation into risk factors and preventive measures is warranted.